Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.schres.2025.05.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Identification and validation of synergistic drug strategies targeting macrophage polarization in triple-negative breast cancer via single-cell transcriptomics and deep learning" [Translational Oncology 2025 Jun 26;59:102457].
Transl Oncol
October 2025
Laboratory of Molecular Genetics of Aging & Tumor, Medicine School, Kunming University of Science and Technology, China.
Corrigendum to "Matrin3 stimulates IFITM1 expression to negatively regulate hepatitis B virus RNA levels" [Int. J. Biol. Macromol. Vol. 319, Part 1, August 2025, 145277].
Int J Biol Macromol
August 2025
The Key Laboratory of Molecular Biology of Infectious Diseases designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China. Electronic address:
Corrigendum to "Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer" [604 (2024) 217219 1-12].
Cancer Lett
October 2025
UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX, 75390, USA. Electronic address:
Corrigendum to "SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer" [J. Ethnopharmacol. 266 (2021) 113430].
J Ethnopharmacol
June 2025
Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China. Electronic address:
Corrigendum to "Antimicrobial peptide WK-13-3D promotes apoptosis, autophagy, and ubiquitination in triple-negative breast cancer via binding immunoglobulin protein (BiP)" [Chem. Biolog. Interact. 415 (2025) 111530].
Chem Biol Interact
September 2025
College of Laboratory Medicine, Ningxia Medical University, Yinchuan, 750004, PR China; Ningxia Key Laboratory of Clinical Pathogenic Microorganisms, Ningxia Medical University, Yinchuan, 750004, PR China. Electronic address: